Scemblix-H-C-PSUSA-00011008-202210 EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Scemblix-H-C-PSUSA-00011008-202210 EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Scemblix-H-C-PSUSA-00011008-202210 EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Stärke
Scemblix-H-C-PSUSA-00011008-202210 EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Packungsgröße
Scemblix-H-C-PSUSA-00011008-202210 EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Form
Scemblix-H-C-PSUSA-00011008-202210 EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Quelle
European Medicines Agency
Sicherheitsprofil
Kontraindikationen
Nebenwirkungen
Scanne diesen QR-Code, um schnell auf diese Seite auf deinem Mobilgerät zuzugreifen.